Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization

被引:0
|
作者
Kuang, Donglin [1 ]
Zhang, Nan [1 ]
Zhang, Mengfan [1 ]
Li, Hao [1 ]
Han, Xinwei [1 ]
Ren, Jianzhuang [1 ]
Duan, Xuhua [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent Radiol, Zhengzhou, Henan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; drug-eluting bead transcatheter arterial chemoembolization; magnetic resonance imaging; margin enhancement; morphology; MICROVASCULAR INVASION; TRANSARTERIAL CHEMOEMBOLIZATION; HEPATIC-TUMORS; ABLATION; CT; MR; MICROSPHERES; PREDICTION; SURVIVAL; CANCER;
D O I
10.3389/fonc.2023.957710
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThe aim of this study is to investigate the morphological characteristics and clinical significance of magnetic resonance (MR) images of peritumor margin enhancement in hepatocellular carcinoma (HCC) after drug-eluting bead transcatheter arterial chemoembolization (DEB-TACE). MethodsFrom January 2017 to December 2020, a total of 162 patients who received a diagnosis of HCC were included in our study. We began the follow-up with magnetic resonance imaging (MRI) for complete response assessment, and peritumor margin enhancements were classified as sharp and rough types according to morphology. During the follow-up, data such as progression or remission of the two enhancement modalities, morphological changes in terms of margin enhancements observed in MR images, and alpha-fetoprotein (AFP) levels were recorded. ResultsIn the follow-up period of 36 months, 70 and 92 patients with sharp- and rough-type peritumor margins, respectively, were observed. At the end of the follow-up, patients with sharp-type margins had lower AFP levels and longer progression-free survival than those with rough-type margins (P < 0.05). Furthermore, the sharp-type margin was thinner than the rough-type margin (all P < 0.05). Moreover, the sharp-type group had a high incidence of tumors with a diameter of < 5 cm, whereas the rough-type group had a high incidence of tumors with a diameter of >= 5 cm. Continuous enhancements of peritumor margins in MRI were greater in the sharp-type group than in the rough-type group. Most of the patients with a sharp-type margin achieved disease remission (94.3%, P < 0.05), whereas most of those with a rough-type margin experienced disease progression (84.8%, P < 0.05). ConclusionsPatients with HCC with a sharp-type margin enhancement on MRI after DEB-TACE mostly demonstrated benign lesions with a good prognosis, whereas those with a rough-type margin mostly demonstrated malignant growth.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study
    Xing, Minzhi
    Webber, Grant
    Prajapati, Hasmukh J.
    Chen, Zhengjia
    El-Rayes, Bassel
    Spivey, James R.
    Pillai, Anjana A.
    Kim, Hyun S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (07) : 1167 - 1174
  • [42] Effectiveness of drug-eluting bead transarterial chemoembolization versus conventional transarterial chemoembolization for small hepatocellular carcinoma in Child-Pugh class A patients
    Lee, In Joon
    Lee, Jeong-Hoon
    Lee, Yun Bin
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Yin, Yona Hu
    Lee, Myungsu
    Hur, Saebeom
    Kim, Hyo-Cheol
    Jae, Hwan Jun
    Chung, Jin Wook
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [43] Diffuse biliary peritonitis secondary to rupture of metastatic liver adenocarcinomas after drug-eluting bead transcatheter arterial chemoembolization: a case report
    Zhu, Lin-Bo
    Li, Tie-Feng
    Li, Jun-Qiang
    Li, Peng-Fei
    Zhang, Peng-Bin
    Wu, Hua-Bin
    Xv, Rong
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (06) : 2679 - 2686
  • [44] A comparison between drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis of six randomized controlled trials
    Wang, Hongye
    Cao, Cheng
    Wei, Xiyi
    Shen, Kangjie
    Shu, Yimei
    Wan, Xiaojie
    Sun, Jinyu
    Ren, Xiaohan
    Dong, Yuxiang
    Liu, Yihai
    Zhai, Bo
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (02) : 243 - 249
  • [45] Safety and Efficacy of Doxorubicin Drug-eluting Bead Transarterial Chemoembolization in Patients with Advanced Hepatocellular Carcinoma
    Prajapati, Hasmukh J.
    Dhanasekaran, Renumathy
    El-Rayes, Bassel F.
    Kauh, John S.
    Maithel, Shishir K.
    Chen, Zhengjia
    Kim, Hyun S.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2013, 24 (03) : 307 - 315
  • [46] ASPP2 expression predicts the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization
    Mao, Jiaren
    Tan, Zhongjun
    Pan, Xiaoqi
    Meng, Feijian
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (04)
  • [47] Analysis of survival and prognostic factors in treatment of hepatocellular carcinoma in Spanish patients with drug-eluting bead transarterial chemoembolization
    Sanchez-Delgado, Jordi
    Vergara, Mercedes
    Machlab, Salvador
    Lira, Alba
    Gomez Zaragoza, Carlos
    Criado, Eva
    Rosinach, Merce
    Batista, Lissette
    Arau, Beatriz
    Roget, Merce
    Ortiz, Jordi
    Garcia, Caridad
    Sort, Pau
    Casas, Meritxell
    Dalmau, Blai
    Forne, Montserrat
    Falco, Joan
    Miquel, Mireia
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (12) : 1453 - 1460
  • [48] Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial
    Duan, Xuhua
    Li, Hao
    Kuang, Donglin
    Chen, Pengfei
    Zhang, Mengfan
    Li, Tengfei
    Jiao, Dechao
    Li, Yanliang
    He, Xiang
    Xing, Cheng
    Wang, Haibo
    Liu, Yaoxian
    Xie, Limin
    Zhang, Shixi
    Zhang, Qiang
    Zhu, Peixin
    Chang, Yongchuang
    Xie, Jichen
    Ren, Jianzhuang
    Han, Xinwei
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [49] Retrospective Study of the Efficacy and Safety of Chemoembolization with Drug-Eluting Microspheres Combined with Intra-Arterial Infusion of Bevacizumab for Unresectable Hepatocellular Carcinoma
    Ueda, Shota
    Hori, Shinichi
    Hori, Atsushi
    Makitani, Kazuhiro
    Wan, Ke
    Sonomura, Tetsuo
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 973 - 985
  • [50] Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study
    Zhang, Lei
    Sun, Jun-Hui
    Ji, Jian-Song
    Zhong, Bin-Yan
    Zhou, Guan-Hui
    Song, Jing-Jing
    Hou, Zhong-Heng
    Huang, Peng
    Zhang, Shen
    Li, Zhi
    Zhu, Xiao-Li
    Ni, Cai-Fang
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2021, 217 (04) : 933 - 943